Virtual BELNUC’21 Symposium
 |
Virtual BELNUC Symposium 2021 Online one-day symposium on May 8th, 2021 |
A virtual one-day symposium on May 8th 2021
REGISTRATION IS CLOSED (Deadline: May 05, 2021)
Thank you for attending!
YNC Award Winners
After counting the (close!) votes, BELNUC is proud to announce the winners of this year’s Young Nuclearist Challenge:
1st prize (€300): dr. J. Gebruers (117 points)
2nd prize (€200): dr. A. Deleu (110 points)
3rd prize (€100): dr. N. Ahmadi (109 points)
Congratulations to the winners and thank you to all authors who submitted their work to BELNUC!
Trophy hunt
The winner of the exhibition trophy hunt will be announced in the June newsletter!
Programme
You can download the final program here.
| Bone SPECT/CT: Joint forces in joint disease | 09:00 – 09:30 | Knives out: Operative techniques in foot and ankle surgery | S. Desmyter | |||
| 09:30 – 10:00 | Seeing is believing: SPECT/CT in foot and ankle pain | G. Gnanasegaran | ||||
| 10:00 – 10:30 | Extinguishing the fire: radiosynoviorthesis in joint synovitis | K. Liepe | ||||
| Young Nuclearist Challenge | 11:00 – 11:10 | Solitary intense striatal hypermetabolism in candida encephalitis. | D. Van Weehaeghe | |||
| 11:10 – 11:20 | An Unexpected Culprit of SVC Syndrome | N. Ahmadi | ||||
| 11:20 – 11:30 | MEN-1 and hibernoma: a serendipitous association? | L. Guillaume | ||||
| 11:30 – 11:40 | Painful ophthalmoplegia in a patient with a history of marginal zone lymphoma. | C. Van Bogaert | ||||
| 11:40 – 11:50 | Recurrent “occult” 18F-FDG uptake in an atypical case of antineutrophil cytoplasmic antibody-associated vasculitis. | A. Castiaux | ||||
| 11:50 – 12:00 | Small, but brave. | L. De Mey | ||||
| 12:00 – 12:10 | Fever of unknown origin: the quest for the crown. | A. Deleu | ||||
| 12:10 – 12:20 | Case of insulinoma treated with PRRT. | G. O. Wetshosele | ||||
| 12:20 – 12:30 | Theragnostics: what you see, is what you treat. | J. Gebruers | ||||
| Oncology Update | 14:00 – 14:45 | Novel fluor-based PET tracers in oncology | C. Deroose | |||
| 14:45 – 15:30 | Lung cancer and immunotherapy: How to read a PET-CT? | N. Aide | ||||
| Challenges in the reimbursement of rapid evolving technologies (Ethics & Economy) |
16:00 – 16:25 | Nomenclature and revision of it: impact on nuclear medicine? | B. Dehaes | |||
| 16:25 – 16:50 | From innovation to routine clinical use, a health technology assessment perspective. | F. Hulstaert | ||||
| 16:50 – 17:30 | Nuclear medicine within hospital networks: opportunities in the short and long terms | M. van Uytven | ||||
| 17:30 – 17:45 | General Discussion |
| 11:00 – 11:30 | New challenges and achievements in F18 radiochemistry | G. Bormans | ||||
| Radiopharmacy break-out session | 11:30 – 12:00 | Radiobiology for targeted radionuclide therapy | J. Nonnekens | |||
| 12:00 – 12:30 | Difference between IMP an non-IMP clinical studies with radiopharmaceuticals | S. De Lombaerde |
| 11:00 – 11:30 | The future of EARL | R. Boellaard | ||||
| Physicist break-out session |
11:30 – 12:00 | Standardization of absolute SPECT / CT quantization | S.Peters | |||
| 12:00 – 12:30 | From the lab to the hospital – standards for radionuclide calibrators | J. Paepen |
Supported by
Industry satellite symposium
| Presented by GE Healthcare |
12:30 – 13:00 | One Birth, One Birthday |
Virtual Poster Area
Poster Area |
Keeping up appearances may cause harm: a breast-implant induced anaplastic large cell lymphoma appearing on [18F]FDG-PET/CT. | S. Vermeulen | ||||
| Evaluation of myocardial uptake of Radium-223 during Xofigo® radiopharmaceutical treatment in a patient with metastatic prostate cancer and cardiac amyloidosis: a case study. | M. Manley | |||||
| Soft-tissue sarcoma mimicking prostate cancer progression evidenced on 68Ga-PSMA-11 PET/CT | Q. Ahmed Shagera | |||||
| C(AVE)AT | A. Geysen | |||||
| Axillary lymph node activation induced by COVID-19 vaccination on FDG PET/CT in a patient with a history of aggressive relapsing lymphoma. | P. Moyaert | |||||
| Another differential diagnosis for lymphoma: Rosai-Dorfman syndrome | G. Lens | |||||
| COVID-19 Post-Vaccinal Lymphadenopathy Mimicking Lymph Node Metastases From Breast Neoplasia | F. Fokoue | |||||
| Suspicious thyroid cold nodule with intense focal 68Ga-DOTATATE uptake: a case report | R. Manta | |||||
| A perfect PMR pattern on FDG PET | L. Boeckxstaens | |||||
Continuing education credits
The BELNUC ’21 Virtual symposium has been accredited with the following continuing education credits:
FANC/AFCN
- 03h00 for nuclear medicine physicians
- 01h30 for physicists qualified in nuclear medicine
- 02h00 for radiopharmacists
RIZIV/INAMI
- 4.5 CP (21002007; category 3; granted)
- 2.0 CP (21002014; category 6; granted)
Federal Public Service: Health, Food Chain Safety, and Environment
- Hospital pharmacists (modules 5; 8 points granted)
Please note that credits are only available when following the symposium live on the day of broadcast.
Young Nuclearist Challenge 2021
Back by popular demand: the Young Nuclearist Challenge 2021 will feature interesting case reports and you will help decide who wins the first prize of €300!